Medicinal composition for treating cardio-cerebral-vascular disease and its preparing method

A cardiovascular and cerebrovascular disease and composition technology, which is applied in cardiovascular system diseases, drug combinations, blood diseases, etc., can solve problems such as insufficient pharmacological effects and unsatisfactory clinical comprehensive effects, and achieve fast onset of action and clear medicinal components. , the effect of high content

Inactive Publication Date: 2006-10-25
上海慈瑞医药科技股份有限公司
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, since cardiovascular and cerebrovascular diseases are complex diseases with multiple factors, the pharmacological effects of drugs with a single component are not comprehensive enough, and the comprehensive clinical curative effect is not ideal.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Take 30g of hydroxysafflower yellow pigment A, 30g of sodium ferulate, 80g of starch as an auxiliary material, 20g of sodium carboxymethylcellulose, and 3g of magnesium stearate, mix well, granulate, and press into 1000 tablets to obtain oral tablets.

Embodiment 2

[0026] Take 10g of hydroxysafflower yellow pigment A, 30g of sodium ferulate, 70g of starch, 10g of lactose, 5g of carboxymethyl cellulose, and 2g of magnesium stearate, mix them evenly, and pack them into 1000 capsules to obtain oral capsules.

Embodiment 3

[0028] Take 5g of hydroxysafflower yellow pigment A and 20g of sodium ferulate, mix them, crush them, pass through a 100-mesh sieve, add 50g of polyethylene glycol 6000 matrix, heat and melt at a temperature of 80-90°C, stir fully and evenly, and transfer to the dripping pill Machine, drop with simethicone as coolant, make 1000 drop pills, promptly get oral drop pills.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a medicine composition for curing angiocardiopathy and cerebrovascular diseases. It is characterized by that the weight ratio of hydroxycarthamus uranidin A and ferulaic acid is 1:0.5-1:5. The invented medicine composition and medicinal auxiliary material can be made into various oral preparations, such as tablet, capsule, dripping pills, oral liquior and injection, etc.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating cardiovascular and cerebrovascular diseases and a preparation method thereof, belonging to the technical field of pharmacy. Background technique [0002] In recent years, cardiovascular and cerebrovascular diseases have become a worldwide health problem. In 2000, the World Health Organization (WHO) reported that stroke and myocardial infarction were the main causes of death in the world, and the number of deaths caused by cardiovascular and cerebrovascular diseases reached 17 million, accounting for one-third of all deaths from all causes. In my country, with the improvement of people's living standards, the change of lifestyle and the acceleration of the pace of life, the death toll of cardiovascular and cerebrovascular diseases in my country has accounted for 1 / 3 of the total death toll. In my country, more than 3 million people die from cardiovascular and cerebrovascular diseases ev...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/351A61K9/00A61K31/192A61K36/232A61K36/236A61K36/286A61P7/02A61P9/00
Inventor 金幸朱益锋汤磊陈林祥王建新
Owner 上海慈瑞医药科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products